Intuitive Surgical, Inc. (NASDAQ:ISRG) is making robotic surgery easier for hospitals to finance. Operating leases accounted for 54% of second-quarter da Vinci placements, up from 49% a year earlier. Lower upfront commitments can expand adoption, but shareholders fund equipment before collecting its lifetime returns. Intuitive Surgical, Inc. (NASDAQ:ISRG) trades at 33x forward P/E and 46x trailing P/E, versus 16x forward P/E for Stryker Corporation (NYSE:SYK). Trailing P/E uses past earnings; forward P/E uses forecasts. Growing procedure volumes and instrument sales support higher expected profits, while a fuller assessment also considers the costs excluded from adjusted earnings.
Wir zeigen den wichtigsten Punkt oeffentlich. Erstellen Sie ein kostenloses Konto, um den vollstaendigen Artikel zu lesen, ihn zu speichern, zu diskutieren und mit Markt- und OSINT-Kontext zu verbinden.
